Howard Mayer

Dr. Howard Mayer, MD, is an Executive Vice President-Research & Development at Ipsen SA, an Independent Director at Entasis Therapeutics Holdings, Inc. and an Executive VP, Head-Research & Development at Ipsen Pharmaceuticals, Inc. He is on the Board of Directors at Adagio Therapeutics, Inc., Entasis Therapeutics Holdings, Inc. and Melmark Charitable Foundation. Dr. Mayer was previously employed as an Independent Director by Genocea Biosciences, Inc., a Chief Medical Officer, Senior VP, Head-R&D by Shire Plc, a Chief Medical Officer by EMD Serono, Inc., a Head-Clinical Development & Medical Affairs by Pfizer Inc., a Director-Infectious Diseases Clinical Research by Bristol Myers Squibb Co., and a Head-Rare Disease Business Unit, R&D by Takeda Pharmaceuticals U.S.A., Inc. He also served on the board at Autism Speaks, Inc. He received his undergraduate degree from the University of Pennsylvania and a doctorate degree from Albert Einstein College of Medicine, Inc..